231 related articles for article (PubMed ID: 825053)
1. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
Mellbye OJ; Naes B; Munthe E
Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
[TBL] [Abstract][Full Text] [Related]
2. Consequences of synovectomy of the knee joint: clinical, histopathological, and enzymatic changes and changes in 2 components of complement.
Myllylä T; Peltonen L; Puranen J; Korhonen LK
Ann Rheum Dis; 1983 Feb; 42(1):28-35. PubMed ID: 6830323
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
4. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
[TBL] [Abstract][Full Text] [Related]
6. Immunopathological changes in rheumatoid arthritis and other joint diseases.
Ghose T; Woodbury JF; Ahmad S; Stevenson B
J Clin Pathol; 1975 Feb; 28(2):109-17. PubMed ID: 1092716
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid in seronegative juvenile rheumatoid arthritis: studies of immunoglobulins, complements, and alpha 2-macroglobulin.
Martin CL; Pachman LM
Arthritis Rheum; 1980 Nov; 23(11):1256-61. PubMed ID: 6160859
[TBL] [Abstract][Full Text] [Related]
8. [Critical considerations on the behavior of immunoglobulins in rheumatoid arthritis].
Troise W; Riccardi L; Bulgarelli G; Sesenna G; Ambanelli U
Ateneo Parmense Acta Biomed; 1975; 46(3):149-61. PubMed ID: 1156463
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of immunoglobulin and complement determination in rheumatoid arthritis].
Bóhrer G; Ambrus M; Bajtai G; Kapisinszky N; Balogh Z
Orv Hetil; 1978 Aug; 119(32):1959-62. PubMed ID: 673413
[No Abstract] [Full Text] [Related]
10. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
11. Immunopathological mechanisms in rheumatoid arthritis at the dual interface of the synovial membrane: the joint cavity and the pannus.
Maini RN
Rheumatol Rehabil; 1979; Suppl():20-9. PubMed ID: 220699
[TBL] [Abstract][Full Text] [Related]
12. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
Stojan B; Hasler F
Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
[TBL] [Abstract][Full Text] [Related]
14. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
15. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the immunological tests in rheumatoid arthritis.
Kim NH; Yang KH; Yang IH
Yonsei Med J; 1989; 30(1):23-9. PubMed ID: 2741472
[TBL] [Abstract][Full Text] [Related]
17. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
Stojan B; Hasler F
Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
[TBL] [Abstract][Full Text] [Related]
18. Synthesis by an established lymphocyte cell line from a rheumatoid synovium.
Gilliland BC; Ford DK; Mannik M
Arthritis Rheum; 1978 Apr; 21(3):330-6. PubMed ID: 417730
[TBL] [Abstract][Full Text] [Related]
19. [Blood and synovial levels of 2 complement fractions].
Ambanelli U; Troise W; Nervetti A
Reumatismo; 1972; 24(3):233-40. PubMed ID: 4549699
[No Abstract] [Full Text] [Related]
20. Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints.
Mellbye OJ; Fyrand O; Brath HK; Olsen E
Clin Exp Immunol; 1980 Apr; 40(1):103-10. PubMed ID: 7389209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
